Bioscience, Biotechnology, and Biochemistry 2002-07-01

Binding selectivity of conformationally restricted analogues of (-)-indolactam-V to the C1 domains of protein kinase C isozymes.

Akiko Masuda, Kazuhiro Irie, Yu Nakagawa, Hajime Ohigashi

Index: Biosci. Biotechnol. Biochem. 66(7) , 1615-7, (2002)

Full Text: HTML

Abstract

Two conformationally restricted analogues of (-)-indolactam-V (1) (cis and trans amides) were examined for their binding selectivity to the synthetic C1 peptides of all protein kinase C (PKC) isozymes. Although the binding constants of the cis amide-restricted analogue (2) were equal to those of 1, the trans amide-restricted analogue (3) bound significantly only to the novel PKC (delta, epsilon, eta, theta) isozymes.

Related Compounds

  • (-)-Indolactam V

Related Articles:

Structural basis of RasGRP binding to high-affinity PKC ligands.

2002-02-14

[J. Med. Chem. 45(4) , 853-60, (2002)]

Tumor promoter binding of the protein kinase C C1 homology domain peptides of RasGRPs, chimaerins, and Unc13s.

2004-09-01

[Bioorg. Med. Chem. 12(17) , 4575-83, (2004)]

Indolactam and benzolactam compounds as new medicinal leads with binding selectivity for C1 domains of protein kinase C isozymes.

2004-01-01

[Curr. Pharm. Des. 10(12) , 1371-85, (2004)]

Protein kinase signalling requirements for metabotropic action of kainate receptors in rat CA1 pyramidal neurones.

2007-03-01

[J. Physiol. 579(Pt 2) , 363-73, (2007)]

Identification of protein kinase C activation as a novel mechanism for RGS2 protein upregulation through phenotypic screening of natural product extracts.

2014-10-01

[Mol. Pharmacol. 86(4) , 406-16, (2014)]

More Articles...